Loading company…
Virotech develops cancer treatments and companion diagnostic reagents.
Virotech develops, produces, and sells lysosomal virus products and companion diagnostic reagents. Its products support clinical development across several cancer indications, including liver, lung, and colorectal cancers. Founded in 2015, the company is based in Guangzhou, China. It raised a strategic investment from Green Pine Capital Partners in November 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in